Nitric oxide releasing prodrugs of diaryl2-(5H)-furanones as cyclooxygenase-2 inhibitors

Details for Australian Patent Application No. 2005206229 (hide)

Owner Merck Frosst Company

Inventors Sturino, Claudio F.; Wang, Zhaoyin; Berthelette, Carl; Li, Lianhai; Beaulieu, Christian

Agent Spruson & Ferguson

Pub. Number AU-A-2005206229

PCT Pub. Number WO2005/070874

Priority 60/540,101 27.01.04 US

Filing date 25 January 2005

Wipo publication date 4 August 2005

International Classifications

C07C 317/46 (2006.01) Sulfones

A61K 31/04 (2006.01) - Nitro compounds

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

24 August 2006 PCT application entered the National Phase

  PCT publication WO2005/070874 Priority application(s): WO2005/070874

18 December 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005206237-Elevator cabin door

2005206228-Nitric oxide releasing prodrugs of diaryl2-(5H)-furanones as cyclooxygenase-2 inhibitors